(1) A pharmacist may select a generic equivalent drug product or an interchangeable biological product only when such selection results in lower cost to the purchaser, unless product selection is expressly prohibited by the prescriber.
(2) A pharmacist shall select a generic equivalent drug product or an interchangeable biological product when:(a) The purchaser requests the selection of a generic equivalent drug product or an interchangeable biological product; or(b) The prescriber has not expressly prohibited product selection; and(c) Product selection will result in lower cost to the purchaser.
(a) The purchaser requests the selection of a generic equivalent drug product or an interchangeable biological product; or
(b) The prescriber has not expressly prohibited product selection; and
(c) Product selection will result in lower cost to the purchaser.
(3) When requested by the purchaser to dispense the drug product or biological product as ordered by the prescriber, a pharmacist shall not select a generic equivalent drug product or an interchangeable biological product.
(4) The board shall maintain a link on its website to the federal Food and Drug Administration’s List of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations.